Finder makes money from featured partners, but editorial opinions are our own.

How to buy MGC Pharmaceuticals (MXC) shares in Australia

Learn how to easily invest in MGC Pharmaceuticals shares.

MGC Pharmaceuticals is a drug manufacturers - specialty & generic business based in Australia. MGC Pharmaceuticals shares (MXC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. MGC Pharmaceuticals has a trailing 12-month revenue of around $1.3 million. If you're looking to buy shares, check out the steps below.

How to buy shares in MGC Pharmaceuticals

To buy shares listed in Australia such as MGC Pharmaceuticals, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.

  1. Open and fund your brokerage account.
    Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  2. Search for MGC Pharmaceuticals.
    Find the share by name or ticker symbol: MXC. Research its history to confirm it's a solid investment against your financial goals.
  3. Purchase now or later.
    Buy today with a market order or use a limit order to delay your purchase until MGC Pharmaceuticals reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
  4. Decide on how many to buy.
    At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  5. Check on your investment.
    Congratulations, you own a part of MGC Pharmaceuticals. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.

MGC Pharmaceuticals stock price (ASX:MXC)

Use our graph to track the performance of MXC stocks over time.

MGC Pharmaceuticals shares at a glance

Information last updated 2024-04-25.
52-week range$0.3 - $9
50-day moving average $0.4198
200-day moving average $1.2904
Target price$20.12
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.21

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Asset class
Finder AwardExclusive
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
CFD service. Capital at risk.
Join the world's biggest social trading network when you trade stocks, commodities and currencies from the one account.
Tiger Brokers
Tiger Brokers
ASX shares, Global shares, US shares, ETFs
Finder exclusive: 10 no-brokerage US or ASX market trades in the first 180 days + 7% p.a. on uninvested cash with first deposit of any amount, plus US$30 TSLA + US$30 NVDA shares with deposits up to AU$2000. T&Cs apply.
Trade Australian, US and Asian stocks with no minimum deposit on Tiger Broker’s feature-packed platform.
CMC Invest
Finder Award
CMC Invest
ASX shares, Global shares, Options trading, US shares, ETFs
$0 brokerage on US, UK, Canadian and Japanese markets (FX spreads apply).
Trade over 45,000 shares and ETFs from Australia and 15 major global markets. Plus, buy Aussie shares or ETFs for $0 brokerage up to $1,000 (First buy order of each security, each day - excludes margin loan settled trades).
ASX shares, Global shares, Options trading, US shares, ETFs
Get 30 days of $0 brokerage fees when you open your account. Receive $50 of TSLA shares and a $50 trading voucher when you deposit $200. T&Cs apply.
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Saxo Invested
Saxo Invested
ASX shares, Global shares, Options trading, US shares, ETFs
Access 22,000+ stocks on 50+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
Go to site

Is it a good time to buy MGC Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

MGC Pharmaceuticals price performance over time

Historical closes compared with the last close of A$0.415

1 month (2024-04-23) -2.35%
3 months (2024-02-23) -1.19%
6 months (2023-11-23) -42.76%
1 year (2023-05-19) inf%
2 years (2022-05-19) inf%
3 years (2021-05-21) -99.19%
5 years (2019-05-23) -99.30%

MGC Pharmaceuticals financials

Revenue TTM $1.3 million
Gross profit TTM $1.3 million
Return on assets TTM -58.96%
Return on equity TTM -307.4%
Profit margin 0%
Book value 0.037
Market capitalisation $18.4 million

TTM: trailing 12 months

MGC Pharmaceuticals share dividends

We're not expecting MGC Pharmaceuticals to pay a dividend over the next 12 months.

Have MGC Pharmaceuticals's shares ever split?

MGC Pharmaceuticals's shares were split on a 1:1000 basis on 29 October 2023. So if you had owned 1000 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your MGC Pharmaceuticals shares – just the quantity. However, indirectly, the new 99900% higher share price could have impacted the market appetite for MGC Pharmaceuticals shares which in turn could have impacted MGC Pharmaceuticals's share price.

MGC Pharmaceuticals share price volatility

Over the last 12 months, MGC Pharmaceuticals's shares have ranged in value from as little as $0.3 up to $9. A popular way to gauge a stock's volatility is its "beta".

MXC.AU volatility(beta: 1.03)Avg. volatility(beta: 1.00)LowHigh

Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while MGC Pharmaceuticals's is 1.028. This would suggest that MGC Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).

MGC Pharmaceuticals overview

MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. In addition, the company provides Irnican that is in preclinical phase for the tetrahydrocannabinol, as well as offers ArtemiC and non-pharma products. Further, it offers consulting services, including clinical research services. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.

MGC Pharmaceuticals in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask a Question

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our 1. Terms Of Service and 6. Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site